Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender.
Jeffrey R Curtis; Leslie A McClure; Elizabeth Delzell; Virginia J Howard; Eric Orwoll; Kenneth G Saag; Monika Safford; George Howard (Profiled Author: Eric Orwoll)
Journal of general internal medicine. 2009;24(8):956-962.Abstract
BACKGROUND: Undertreatment of osteoporosis has been recognized as a common problem in selected patient subgroups. However, primary prevention has been hampered by limited risk assessment tools that can be applied to large populations. OBJECTIVES: Using clinical risk factors with a new tool from the World Health Organization (FRAX) and recommendations from the National Osteoporosis Foundation (NOF), we evaluated fracture risk and osteoporosis treatment in a US cohort. PARTICIPANTS: African Americans and Caucasians recruited from 2003-7 across the US as part of a longitudinal study. DESIGN: Cross-sectional. MEASURES: The number of persons receiving prescription osteoporosis medications was assessed by race, sex, and fracture risk. Multivariable logistic regression evaluated the association between receipt of osteoporosis medications and fracture risk after controlling for potential confounders. RESULTS: Among 24,783 participants, estimated fracture risk was highest for Caucasian women. After multivariable adjustment for fracture-related risk factors, the likelihood of receipt of osteoporosis medications among African Americans was lower than among Caucasians [odds ratio (OR) = 0.44, 95% confidence interval (CI) 0.37, 0.53] and for men compared to women (OR = 0.08, 95% CI 0.06-0.10). Even for the highest risk group, Caucasian women with 10-year hip fracture risk > or = 3% (n = 3,025, 39.7%), only 26% were receiving treatment. CONCLUSIONS: A substantial gap exists between 2008 NOF treatment guidelines based on fracture risk and the receipt of prescription osteoporosis medications. This gap was particularly notable for African Americans and men. FRAX is likely to be useful to assess risk at a population level and identify high-risk persons in need of additional evaluation.
PMID: 19551449 PMCID: PMC2710475
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Jane A. Cauley; Susan K. Ewing; Brent C. Taylor; Howard A. Fink; Kristine E. Ensrud; Douglas C. Bauer; Elizabeth Barrett-Connor; Lynn Marshall; Eric S. OrwollJournal of Clinical Endocrinology and Metabolism. 2010;95(9):4314-4323.
Benjamin Lebwohl; Christina A. Tennyson; Jennifer L. Holub; David A. Lieberman; Alfred I. Neugut; Peter H.R. GreenGastrointestinal Endoscopy. 2012;76(4):779-785.
Jane A. Cauley; Robin L. Fullman; Katie L. Stone; Joseph M. Zmuda; Douglas C. Bauer; Elizabeth Barrett-Connor; Kristine Ensrud; Edith M. C. Lau; Eric S. OrwollOsteoporosis International. 2005;16(12):1525-1537.
Appears in this Document